State Street Corp Night Hawk Biosciences, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$2.1 - $3.54 $8,582 - $14,467	4,087 Added 4.13%	102,983 $315,000
Q2 2021 Aug 16, 2021	BUY	$5.78 - $9.6 $470,723 - $781,824	81,440 Added 466.54%	98,896 $666,000
Q1 2021 May 17, 2021	BUY	$5.67 - $12.54 $6,804 - $15,047	1,200 Added 7.38%	17,456 $127,000
Q4 2020 Feb 16, 2021	BUY	$5.28 - $9.59 $85,831 - $155,895	16,256 New	16,256 $87,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.